ESAB Reports Q2 2026 Earnings Miss on EPS but Beats Revenue Forecast

ESAB posted second‑quarter earnings of $1.33 per share, falling short of the $1.37 consensus, while revenue rose to $807.63 million, surpassing the $749.05 million estimate. The company lifted its FY 2026 EPS guidance to $5.40‑$5.50 and raised its sales outlook to $3.0‑$3.1 billion.

ICU Medical reported Q2 revenue of $551.7 million and earnings of $0.76 per share. Adjusted earnings of $2.37 per share beat analysts’ $1.91 expectation. The firm raised its FY 2026 adjusted EBITDA guidance to $415‑$435 million and its adjusted EPS target to $8.60‑$9.00, sending the stock up more than 10 percent.

Urban Edge Properties delivered $0.14 earnings per share versus the $0.11 forecast, with revenue of $122.78 million beating the $117.86 million consensus. The REIT announced record adjusted FFO of $0.40 per share, a 10 % year‑over‑year increase, and raised its FY 2026 FFO guidance to $1.50‑$1.54 per share. Occupancy metrics showed slight declines, but management expects recovery by year‑end.